fashion -WSS

fashion

author：hotspot 2025-10-01 20:15:09 - browse：9

FogPharma CEO Mathai Mammen Venrock

SAN FRANCISCO — Six months into his tenure as CEO of cancer startup FogPharma, Mathai Mammen is taking the stage at the Westin St. Francis Tuesday for what he’s calling a “big unveil” of how he’s reshaping the biotech. And he’s prepared to go against the grain.

Perhaps the most important thing he’s telling investors at the J.P. Morgan Healthcare Conference is that he plans to eventually pursue a rare Series E round, rather than an IPO or seeking out acquisition offers.

FogPharma last raised money in November 2022, and will need more cash to bring its lead drug past its ongoing Phase 1/2 trial. Most other biotechs in this position are anxiously eyeing the capital markets, hoping that conditions improve and make an IPO more feasible. But Mammen doesn’t see the point, at this stage. “There’s no reason to be a public company. I don’t know why you’d want to be, really,” he told STAT ahead of FogPharma’s presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Kaiser's Risant Health gobbled up Geisinger. Who is next?

leisure time

Wikipedia

WSS

ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Are embryos people? Reproductive medicine's future depends on the answer

HIV drugs protect against transmission, even in unprotected sex

hotspot

fashion

entertainment

New air purifier tech could be key to improving indoor air quality

The Pandemic Treaty must support building strong health systems

ChatGPT in medicine: STAT answers readers' burning questions

BMI, flaws aside, is found to be useful estimate of body fat in youth

In Memoriam: Notable people who died in 2023

Children’s Hospital revives plan for pedestrian bridge

Hepatitis C has a cure — but many Americans still lack access to it

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Psychedelics group wrestles with new pharma identity

Study fuels hope CAR

hotspot

Cord blood banking comes at a high cost to babies

BMI, flaws aside, is found to be useful estimate of body fat in youth

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Study fuels hope CAR

CDC advisory group OKs chikungunya vaccine

Let's speed up science by embracing open access publishing

leisure time

Wikipedia

Wikipedia

hotspot